Shares of Global Medical REIT Inc (NYSE:GMRE) have earned a consensus recommendation of “Buy” from the eight research firms that are currently covering the stock, MarketBeat reports. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $10.61.
Several research analysts have issued reports on the company. ValuEngine lowered Global Medical REIT from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Zacks Investment Research upgraded Global Medical REIT from a “strong sell” rating to a “hold” rating in a research note on Thursday, July 11th. Finally, TheStreet lowered Global Medical REIT from a “b” rating to a “c+” rating in a research note on Thursday, August 8th.
In other Global Medical REIT news, Director Ronald Marston bought 3,000 shares of the stock in a transaction dated Monday, August 26th. The stock was bought at an average cost of $10.70 per share, for a total transaction of $32,100.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 11.70% of the company’s stock.
Global Medical REIT stock traded down $0.20 during mid-day trading on Friday, hitting $11.46. 455,722 shares of the company were exchanged, compared to its average volume of 197,048. The company has a quick ratio of 0.14, a current ratio of 0.14 and a debt-to-equity ratio of 1.13. The business has a fifty day moving average of $10.76 and a 200 day moving average of $10.47. Global Medical REIT has a 1-year low of $8.15 and a 1-year high of $11.68. The company has a market capitalization of $406.36 million, a PE ratio of 14.69 and a beta of 0.38.
Global Medical REIT (NYSE:GMRE) last released its quarterly earnings data on Wednesday, August 7th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($0.16). Global Medical REIT had a return on equity of 5.91% and a net margin of 24.11%. The company had revenue of $16.88 million for the quarter, compared to analyst estimates of $16.74 million. Research analysts expect that Global Medical REIT will post 0.74 earnings per share for the current year.
The business also recently disclosed a — dividend, which will be paid on Thursday, October 10th. Shareholders of record on Wednesday, September 25th will be paid a dividend of $0.20 per share. The ex-dividend date of this dividend is Tuesday, September 24th. This represents a yield of 7.1%. Global Medical REIT’s dividend payout ratio is currently 102.56%.
Global Medical REIT Company Profile
Global Medical REIT, Inc engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.
Read More: Why do corrections happen?
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.